Aphria Inc. Announces Completion of First EU-GMP Shipment to Germany
Expects first sales of Aphria-branded cannabis in Germany in Q2 FY2021 LEAMINGTON, ON, Oct. 7, 2020 /PRNewswire/ – Aphria Inc. (“Aphria” or the “Company“) (TSX:
Read more
EU GMP
Zenabis Obtains EU-GMP Approval to Supply Medical Cannabis to Europe and Amendments to Health Canada License
VANCOUVER, May 20, 2020 /CNW/ – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company“) is pleased to announce that it has successfully
Read more
Aleafia Health Subsidiary Emblem Germany Submits EU-GMP Certification Application
Successful application would allow for cannabis production and export to EU market Emblem Germany cannabis distribution center to be completed
Read more
Aphria Inc. Announces Receipt of EU GMP Certification for Subsidiary ASG Pharma Ltd. and Liquidation of Promissory Note
LEAMINGTON, ON, May 6, 2020 /PRNewswire/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today announced that its subsidiary, ASG Pharma Ltd.
Read more